Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 4:11 PM ET

Date/Time Source News Release
04/30/2025 12:50 PM EDT GlobeNewswire Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
04/16/2025 12:45 PM EDT GlobeNewswire Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
04/09/2025 01:40 PM EDT GlobeNewswire Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L
04/08/2025 10:45 AM EDT GlobeNewswire Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order
02/26/2025 11:30 AM EST ACCESS Newswire Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates
02/18/2025 08:30 AM EST ACCESS Newswire Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1
02/11/2025 10:15 AM EST ACCESS Newswire Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market
02/10/2025 01:30 PM EST ACCESS Newswire Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market
02/10/2025 09:45 AM EST ACCESS Newswire Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations
02/07/2025 10:00 AM EST ACCESS Newswire Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility
Page

Additional News

As of April 30, 2025 • 4:11 PM ET

Date/Time Source News Release
04/08/2025 11:48 AM EDT SeekingAlpha Cosmos Health launches Sky Premium Life in Albania, secures $0.3M order
01/13/2025 09:55 AM EST SeekingAlpha Cosmos Health announces distribution agreement with Virax Biolabs
12/18/2024 05:44 PM EST SeekingAlpha Cosmos Health files to sell common stock, warrants
11/20/2024 06:08 PM EST SeekingAlpha Henry Schein: Another Day, Another Purchase
11/16/2024 04:36 AM EST US Earnings Reports Expected earnings - Cosmos Health Inc.
11/14/2024 08:40 AM EST Zacks Ocular Therapeutix (OCUL) Reports Q3 Loss, Lags Revenue Estimates
11/13/2024 05:20 PM EST Zacks 4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates
11/12/2024 05:55 PM EST Zacks Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
11/07/2024 08:15 AM EST Zacks Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
10/28/2024 05:49 PM EDT SeekingAlpha Cosmos Health files secondary offering of shares
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.